Hematology & Medical Oncology

Cancer Answer Line: 866.223.8100

Cancer Answer Line:

866.223.8100

The Department of Hematology & Medical Oncology is comprised of physicians, nurses, researchers, and other healthcare professionals specializing in the diagnosis and treatment of patients with cancers or disorders of the blood, solid organs, or soft tissues.

The department includes several programs devoted to specific disease or treatments such as chronic leukemia and multiple myeloma, blood and marrow transplantation, and palliative medicine.

Acute Leukemia Program»

The Acute Leukemia Program at Cleveland Clinic Taussig Cancer Institute is a worldwide leader in the treatment of acute myeloid and lymphoblastic leukemia. Patients are managed on a dedicated inpatient unit by a multidisciplinary team.

The Acute Leukemia Program features the most innovative treatments including several national studies for which Cleveland Clinic physicians serve as principal investigators. Patients benefit from both the special expertise of the program’s physicians and close collaboration with the Bone Marrow Transplant Program.

Benign Hematology Program»

The department offers evaluation, treatment, and consultative services in the field of benign and malignant hematologic disorders. The benign areas include disorders of:

  • Red cells, white cells, platelets
  • Hemostasis and thrombosis
  • Genetic disorders, such as hemoglobinopathies, enzymatic disorders, and the porphyrias
  • Diagnostic work up of symptomatic presentations, such as fevers, lymphadenopathy, and complications of solid organ transplantation.

Bone Marrow Failure Program»

Dedicated to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS), aplastic anemia, paroxysmal nocturnal hemoglobinuria, and other bone marrow failure conditions, the Bone Marrow Failure program has been recognized as a leader in pioneering diagnostic techniques and therapies by patient groups and national and international treatment and research organizations.

The Bone Marrow Failure program is led by nationally recognized physicians who work closely with specialty nurses and support staff to provide personalized, disease-directed care. .

Bone Marrow Transplant Program»

Cleveland Clinic’s Bone Marrow Transplant Program is internationally recognized as a leader in the field. Autologous, allogeneic, non-myeloablative, bone marrow, peripheral stem cell and umbilical cord blood transplants are performed for patients with leukemias, lymphomas, and other hematological malignancies and bone marrow failure states.

As one of the most productive clinical research programs in the world, our physicians have performed over 3,000 bone marrow transplant procedures. Our large referral base and excellent community physician relationships allows for successful continuity of care, making us a leader among bone marrow transplant centers.

Chronic Leukemia & Multiple Myeloma Program»

The Chronic Leukemia and Multiple Myeloma Program provides patients and physicians access to innovative treatment options, recognized medical expertise, and dedicated support resulting in superior outcomes.

These patients are evaluated and managed by a multidisciplinary team comprised of physicians, nurses and social workers. The program offers patients clinical trials of promising agents and works closely with the lab in developing new, innovative approaches to treatment.

Health Information

Contact Information

Patient Referrals or Questions:

Debbie Hastings
Department Coordinator
Phone: 216.445.5008
Email: hastind@ccf.org

Cancer Answer Line
Toll-free: 866.223.8100
Email: myeloma@ccf.org


»Education

The better educated the patient and his or her family are about cancer usually results in a better outcome of therapy. A patient who understands the disease will tend to be able to identify problems sooner and is usually able to follow instructions better. The Taussig Cancer Institute provides a Multiple Myeloma Support Group as well as many additional patient support services to assist our patients in his or her time of need.

Information/Educational Material

Cleveland Clinic Chronic Leukemia & Multiple Myeloma Program provides several informational brochures for our patients to review. Please feel free to contact the Cancer Answer Line with any questions or call us locally at 216.445.5008 or toll-free (866.223.8100).

»Resources

The International Myeloma Foundation (IMF)
Toll-free (US & Canada): 800.452.CURE (2873)
Phone (Outside US & Canada): 818.487.7455
Email: TheIMF@myeloma.org
Website: www.myeloma.org

The Multiple Myeloma Research Foundation (MMRF)
Phone: 203.972.1250
Email: info@themmrf.org
Website: www.themmrf.org

»Research

The treatment of multiple myeloma had not changed the course of the disease significantly until the advent of novel therapies in the last 10 years. Now, many patients can expect long remissions and improved survival as a result of groundbreaking treatment advances. Therefore, we believe that active research and new treatment modalities are necessary to achieve our goals in controlling the disease for longer periods of time in even more patients.

Over the past few years a better understanding of the biology of the disease has resulted in a large flux of new promising agents that are being studied at Cleveland Clinic independently and/or in collaboration with other myeloma institutions in the US, Europe, Australia and Asia. This will allow for better treatments, and will hopefully translate into better quality of life and survival for myeloma patients.

Using a multidisciplinary approach to care with colleagues in the departments of nephrology, radiation oncology, orthopedic surgery and palliative medicine, patients at Cleveland Clinic will receive specialized care in hopes of superior outcomes.

Clinical Trials

The Cleveland Clinic Chronic Leukemia & Multiple Myeloma Research Program focuses on new drug development, as well as studying the tumor biology to modify its behavior. Over the past few years the research in the biology area has remarkably improved our understanding to develop less toxic and more rational maintenance therapy. Search our database for a listing of clinical trials available at the Taussig Cancer Institute.

»Support Group

Multiple Myeloma Support/Education Group

Cleveland Clinic Chronic Leukemia & Multiple Myeloma Support and Education Group is designed to provide patients and families with a strong support network as well as educate the patient about his or her disease. It is our belief that a better-educated patient will have a greater chance of survival and a better experience during treatment.

Contact:

Debbie Hastings
216.445.5008

Lymphoma Program»

The Lymphoma Program is a comprehensive, multidisciplinary effort dedicated to the diagnosis and treatment of Hodgkin and non-Hodgkin lymphoma; education and support of patients and their families; investigation of lymphoma pathobiology; and development of innovative treatments.

We review new patients and pathology specimens at a weekly multidisciplinary clinicopathology conference to ensure accurate diagnosis and determine the best available individualized management. In addition to standard treatments (e.g. chemotherapy, monoclonal antibodies, radioimmunoconjugates and hematopoietic stem cell transplantation), we also have available many novel agents such as monoclonal antibodies, vaccines, and targeted therapies.

Palliative Medicine»

Patients with a complex, life-threatening illness often have unrelieved cancer symptoms and significant physical difficulties sometime during their illness. Specially trained staff in the Harry R. Horvitz Center for Palliative Medicine at Cleveland Clinic Taussig Cancer Institute coordinate the complex medical care for patients as they face the physical and psychological challenges associated with their illness and the pain related to cancer symptoms.

Taussig Oncology Program for Seniors (TOPS)»

If you are 75 or older and have been diagnosed with cancer, you may benefit from a specialized assessment at Taussig Cancer Institute's Geriatric Oncology Clinic. The assessment is designed to identify and manage problems related to a cancer diagnosis and treatment that may otherwise get overlooked. The assessment's goal is to improve your quality of life, offer reassurance to you and your family, and empower you to make informed health care decisions.

Matt Kalaycio, MD, FACP (Department Chairman)

Cleveland Clinic Main Campus

Matt Kalaycio, MD, FACP, is Chairman of the Department of Hematology & Medical Oncology at Cleveland Clinic Taussig Cancer Institute. Dr. Kalaycio holds a joint appointment in Cleveland Clinic's Transplant Center and is a Staff member in the Department of Hematology & Medical Oncology.

Additionally, Dr. Kalaycio is a Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is board-certified in hematology, medical oncology and internal medicine. Dr. Kalaycio's clinical interests include leukemia and stem cell transplantation.




Jame Abraham, MD

Cleveland Clinic Main Campus

Jame Abraham, MD, was appointed in 2013 as Director of the Breast Oncology Program at Taussig Cancer Institute.

Dr. Abraham received his medical degree from Calicut University Medical College in India. He completed an internal medicine residency at University of Connecticut. He then earned two fellowships, one from the National Heart, Lung and Blood Institute and the other from National Cancer Institute, both in Bethesda, MD.




David Adelstein, MD

Cleveland Clinic Main Campus

David Adelstein, MD, is a Staff Physician in the Department of Hematology & Medical Oncology at Taussig Cancer Institute, and he is a Professor of Medicine in Cleveland Clinic's Lerner College of Medicine of Case Western Reserve University. Dr. Adelstein is also Co-Chairman of the National Cancer Institute Head and Neck Cancer Steering Committee.

Dr. Adelstein completed his undergraduate education at the University of Chicago, his medical school training at New York University School of Medicine, and his internship, residency and hematology/oncology fellowship at Case Western Reserve University Hospitals.




Anjali Advani, MD

Cleveland Clinic Main Campus

Anjali S. Advani, MD, is a Staff Physician in the Department of Hematology & Medical Oncology and Blood Disorders and Director of the Inpatient Leukemia Program at Taussig Cancer Institute. She is also Assistant Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

She completed her medical degree, internal medicine residency, and hematology and oncology fellowship at Duke University Medical Center. She has been at Cleveland Clinic since 2002.




Steven Andresen, DO

Cleveland Clinic Main Campus

Steven Andresen, DO, has been a Staff Physician in the Department of the Hematology & Medical Oncology since 1987. Dr. Andresen attended the University of Iowa and received his medical degree from the University of Osteopathic Medicine and Health Sciences in Des Moines , Iowa.

His specialty interests include bone marrow transplantation, breast cancer, and hematologic malignancies.




Brian Bolwell, MD (Institute Chairman)

Cleveland Clinic Main Campus

Brian Bolwell, MD, is the Chairman of Taussig Cancer Institute at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and has authored more than 300 articles and abstracts concerning hematologic malignancies and bone marrow transplantation.

Dr. Bolwell attended Harvard University and received his medical degree from Case Western Reserve University. Dr. Bolwell completed his medical internship and residency at University Hospitals of Cleveland and a hematology and oncology fellowship at Hospital of the University of Pennsylvania.




G. Thomas Budd, MD

Cleveland Clinic Main Campus

George Thomas Budd, MD, is a staff physician at Cleveland Clinic's Taussig Cancer Institute. His clinical interests include breast cancer, sarcomas, experimental therapeutics, and research.

Dr. Budd received his medical degree from the University of Kansas Medical School. He completed his internship, residency, and fellowship in medical oncology at Cleveland Clinic.




Hetty Carraway, MD

Cleveland Clinic Main Campus

Hetty Carraway, MD, is a Staff physician in the Department of Hematology & Medical Oncology at Cleveland Clinic.

Dr. Carraway earned her medical degree at University of Massachusetts Medical School in Worcester, MA. She then completed both her residency and fellowship at John Hopkins University in Baltimore, MD.




Mellar Davis, MD

Cleveland Clinic Main Campus

Mellar Davis, MD, received his undergraduate degree from Otterbein University, and his medical degree from The Ohio State University College of Medicine and Public Health. He completed an internship and residency at Riverside Methodist Hospital in Columbus, OH and a fellowship at Mayo Clinic in Rochester, MN.

His specialty interests include pain management, cancer pain, palliative medicine, hospice, symptom control, supportive cancer care, cancer related fatigue, cancer anorexia and weight loss, lung cancer, paraproteinemias and amyloidosis.




Robert Dean, MD

Cleveland Clinic Main Campus

Robert Dean, MD, joined the Staff of the Cleveland Clinic Taussig Cancer Institute in 2005. Dr. Dean attended undergraduate and medical school at the University of Pennsylvania. He received his internal medicine training at Boston University Medical Center and studied primary amyloidosis while serving as a research fellow.

Dr. Dean completed a fellowship in hematology and medical oncology at the National Cancer Institute, where he conducted research in allogeneic stem cell transplantation.




Krista Dobbie, MD

Cleveland Clinic Main Campus

Krista Dobbie, MD, was appointed Associate Staff at Cleveland Clinic Taussig Cancer Institute in 2012. She completed her undergraduate degree at University of Pittsburgh and attended medical school at Medical College of Ohio at Toledo. After completing a residency and internship at Eastern Virginia Medical School in Norfolk, VA, Dr. Dobbie earned a fellowship at Lombardi Cancer Center at Georgetown University in Washington, DC.

Some of Dr. Dobbie’s specialty interests include palliative medicine and solid tumor oncology.




Robert Dreicer, MD

Cleveland Clinic Main Campus

Robert Dreicer, MD, M.S., FACP, is a Staff physician in the Department of Hematology & Medical Oncology at Taussig Cancer Institute. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine and board-certified in internal medicine and medical oncology. His areas of specialization are the management of genitourinary malignancies and the design and conduct of clinical trials in urologic oncology.

Dr. Dreicer received his medical degree from the University of Texas Medical School at Houston. He completed an internal medicine residency at Indiana University in Indianapolis, followed by a medical oncology fellowship at the University of Wisconsin Clinical Cancer Center in Madison, WI.




Hien Duong, MD

Cleveland Clinic Main Campus

Hien K. Duong, MD, attended University of Michigan, where she received both her undergraduate and medical degree. She completed her specialty training in hematology and oncology at Cleveland Clinic, and joined as Associate Staff in August 2010.

Dr. Duong's research interests include hematopoietic stem cell transplant and improving stem cell mobilization methods.




Bassam Estfan, MD

Cleveland Clinic Main Campus

Bassam Estfan, MD, received his medical degree at Damascus University-Faculty of Medicine in Damascus, Syria. He completed a residency at Monmouth Medical Center in Long Branch, NJ and two fellowships at Cleveland Clinic: Palliative Medicine and Medical Oncology.

His specialty interests include pain management, cancer pain, cancer related fatigue, cancer anorexia and weight loss, palliative medicine, hospice, symptom control, and cancer supportive care.




Jorge Garcia, MD

Cleveland Clinic Main Campus

Jorge Garcia, MD, received his undergraduate degree at Calasanz College in Santa Fe de Bogota, Colombia and his medical degree at Escuela Colombiana de Medicina in Santa Fe De Bogota, Colombia. He completed a fellowship at Harvard Medical School, an internship and a residency at the Albert Einstein College of Medicine, and two fellowships in Hematology/Medical Oncology and Urologic Oncology at the University of California San Francisco Medical Center.

His specialty interests include clinical trials, experimental therapeutics, and genitourinary malignancies.




Aaron Gerds, MD

Cleveland Clinic Main Campus

Aaron Gerds, MD, is an Associate Staff Physician in the Department of Hematology & Medical Oncology.

Dr. Gerds earned his medical degree at Loyola University Stritch School of Medicine in Chicago, IL. He completed a residency at Loyola University Medical Center in Maywood, IL, and a fellowship at University of Washington Medical Center in Seattle, WA.




Timothy Gilligan, MD

Cleveland Clinic Main Campus

Timothy Gilligan, MD, is a Medical Oncologist at Cleveland Clinic's main campus in Cleveland, Ohio. He is board-certified in medical oncology and internal medicine and specializes in cancers of the testicles, bladder, prostate and kidneys as well as in problems related to cancer survivorship.

Dr. Gilligan has published over half a dozen original scientific articles in peer-reviewed journals, has written several review articles and book chapters and has given numerous lectures on genitourinary cancers and biomedical ethics.




Petros Grivas, MD, PhD

Cleveland Clinic Main Campus

Petros Grivas, MD, PhD is an Associate Staff physician in the Department of Hematology & Medical Oncology at Cleveland Clinic.

Dr. Grivas earned both his MD and PhD from the University of Patras School of Medicine in Greece. He completed a residency in Internal Medicine at Hahnemann University Hospital/Drexel University College of Medicine in Philadelphia, PA. Dr. Grivas completed a fellowship in Hematology/Oncology at the University of Michigan.




Mona Gupta, MD

Cleveland Clinic Main Campus

Mona Gupta, MD, earned her medical degree at Lady Hardinge Medical College & Associated Hospitals in New Delhi, India. She completed an internship in Anesthesiology at Maulana Azad Medical College Associated Hospitals, two residencies at Huron Hospital, and a fellowship in Geriatric Medicine, Hematology/Medical Oncology, and Palliative Medicine at Cleveland Clinic.




Terence Gutgsell, MD

Cleveland Clinic Main Campus

Terence Gutgsell, MD, earned his medical degree at the University of Kentucky College of Medicine in 1972 and completed his internal medicine residency at the A.B. Chandler University of Kentucky Medical Center in 1976. He left his practice of internal medicine in 1995 to complete a palliative medicine fellowship at Cleveland Clinic in 1996.

He served as Medical Director and Chief Medical Officer at Hospice of the Bluegrass, and Medical Director of the Hospice Care Center at St. Joseph Hospital in Lexington, Ky., from 1996-2007. From 1999-2007, he was Medical Director of the Palliative Care Center of the Bluegrass and Medical Director of the Palliative Care Unit at Central Baptist Hospital. His work with Hospice of the Bluegrass and local hospitals in Lexington led to designation of the Palliative Care Center of the Bluegrass as one of six nationally recognized Robert Wood Johnson Palliative Care Leadership Centers (PCLC).




Betty Hamilton, MD

Cleveland Clinic Main Campus

Betty Hamilton, MD, is an Associate Staff Physician in the Department of Hematology & Medical Oncology.

Dr. Hamilton attended medical school at University of Chicago Pritzker School of Medicine. She completed a residency at the Hospital of the University of Pennsylvania in Philadelphia, PA, and a fellowship at Cleveland Clinic.




Brian Hill, MD, PhD

Cleveland Clinic Main Campus

Brian Hill, MD, earned his undergraduate degree from Dartmouth College, followed by his doctorate degree from The State University of New York at Stony Brook. Dr. Hill earned his medical degree at University of Chicago Pritzker School of Medicine and stayed in Chicago to complete a residency in internal medicine at University of Chicago Hospitals. He later completed a fellowship at Cleveland Clinic.

Dr. Hill's specialty interests include chronic lymphocytic leukemia, hematologic malignancies, HIV-related lymphoma, Hodgkin's disease, and non-Hodgkin's lymphoma.




Leonard Horwitz, MD

Cleveland Clinic Main Campus

Leonard Horwitz, MD, graduated magna cum laude from Yale University. He later received his medical degree from Albert Einstein College of Medicine in New York. He completed a residency in internal medicine and fellowship in hematology at Long Island Jewish Hospital. Dr. Horwitz completed a second fellowship in medical oncology at MD Anderson Hospital & Tumor Institute in Houston, Texas.

Dr. Horwitz is a member of the American Medical Association and a fellow in The American College of Physicians and American Society of Clinical Oncology. He is board-certified in hematology, medical oncology, and internal medicine.




Deepa Jagadeesh, MD

Cleveland Clinic Main Campus

Deepa Jagadeesh, MD, is Associate Staff in the Department of Hematology & Medical Oncology in the Lymphoma and Bone Marrow Transplant Programs.

Dr. Jagadeesh received her medical degree at the JJMM Medical College at the University of Mysore in India and completed her internship, residency, and fellowship at University of Massachusetts Medical School.




Alok Khorana, MD

Cleveland Clinic Main Campus

Alok Khorana, MD, is the Sondra and Stephen Hardis Chair in Oncology and Vice-Chair for Clinical Services and Director of the Gastrointestinal Malignancies Program at Taussig Cancer Institute of the Cleveland Clinic.

Dr. Khorana attended medical school at Baroda Medical College at The Maharaja Sayajirao University in India. He completed a residency at Millard Fillmore Gates Circle Hospital/Kaleida Health in Buffalo, NY, and a fellowship at University of Rochester Medical Center in Rochester, NY.




Anna Koo, MD

Cleveland Clinic Main Campus

Anna Koo, MD, is the HPC Apheresis Collection Facility Medical Director and is a Staff Physician in the Department of Hematology & Medical Oncology. She received her medical degree from New Jersey Medical School.

Some of Dr. Koo's professional highlights include: past President of The American Society for Apheresis, board member of the International Society for Apheresis, certified member of the American Board of Rheumatology and Internal Medicine, and editorial board member of Therapeutic Apheresis and Dialysis Journal.




Ruth Lagman, MD

Cleveland Clinic Main Campus

Ruth Lagman, MD, was born in Manilla, Philippines. She finished her Bachelor of Science in Zoology from the University of the Philippines in 1982. She obtained her Doctor of Medicine degree from the University of Santo Tomas, Faculty of Medicine and Surgery, in Manila in 1986. She then spent a year in a clinical-internship followed by a brief stint as a volunteer physician in rural Philippines. Her experience in rural Philippines motivated her to pursue a master’s degree in Public Health at the Department of Epidemiology and Public Health at Yale University with a concentration in the epidemiology of infectious disease. The degree was conferred in 1993 upon completion of her master's thesis.

Dr. Lagman did her internal medicine residency at the University of Connecticut Health Center in Farmington, Conn., from 1990-1993. She then returned home to the Philippines and spent a year teaching at the College of Medicine at Angeles University in Pampanga, Philippines. In 1995, she entered the clinical fellowship program in Palliative Care at Cleveland Clinic. She then spent the next few years in private practice, with general internal medicine in the greater Chicago area. She returned to Cleveland, Ohio, in July 2001 to join the medical staff of the Harry R. Horvitz Center for Palliative Medicine, Department of Hematology and Oncology, at Cleveland Clinic.




Susan LeGrand, MD

Cleveland Clinic Main Campus

A native of South Carolina, Susan LeGrand, MD, joined Cleveland Clinic's pioneering Palliative Medicine program in 1998. Prior to this, she had a solo oncology practice in North Carolina. She received her undergraduate and medical education at the University of South Carolina, graduating cum laude and Phi Beta Kappa. She received the Behavioral Sciences Award in her first year of medical school. Dr. LeGrand is board-certified in internal medicine, medical oncology and hospice and palliative medicine. She was elected a Fellow of the American College of Physicians in 2002.

Dr. LeGrand has been a leader in palliative medicine fellowship education, co-chairing a workgroup to develop standards for fellowship training. She spearheaded the development of a Forum for Program Directors under the auspices of the American Academy of Hospice and Palliative Medicine and chaired that group through its infancy. She is a Master Facilitator for the Education in Palliative and End of Life Care program and was the palliative medicine representative on the Robert Wood Johnson Workgroup to improve end-of-life care for amyotrophic lateral sclerosis.




Alan Lichtin, MD

Cleveland Clinic Main Campus

Alan Lichtin, MD, earned his undergraduate and medical degree at the University of Cincinnati. He completed his internship and residency at University Hospitals of Cleveland and then went on to complete his fellowship in hematology and oncology at University of Pennsylvania.

His specialty interests include adult hematology, coagulation and hemostasis disorders, and hematologic malignancies.




Patrick C. Ma, MD, MS

Cleveland Clinic Main Campus

Patrick C. Ma, MD, MS, was appointed Associate Staff Physician in the Departments of Hematology & Medical Oncology and Translational Hematology and Oncology Research in Cleveland Clinic's Taussig Cancer Institute in 2010. Dr. Ma is the Director of Aerodigestive Oncology Translational Research.

Dr. Ma received his undergraduate degree from University of Hong Kong. He received his graduate and medical degrees from University of Toronto. Dr. Ma studied for his residency at both Toronto General Hospital and Saint Elizabeth Medical Center in Boston, MA. He then completed two fellowships at Dana Farber and New England Medical Center (both in Boston, MA).




Jaroslaw Maciejewski, MD, PhD

Cleveland Clinic Main Campus

Jaroslaw Maciejewski, MD, PhD, is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Maciejewski is also an elected member of The American Society for Clinical Investigators (ASCI). He received his medical and doctorate degree from the Institute for Medical Immunology at Humboldt University Medical School in Berlin, Germany. He completed his internal medicine residency at the University of Nevada School of Medicine and Fellowship at the National Institutes of Health Medical Center in Bethesda, MD. He completed his postdoctoral research fellowship at the National Heart, Lung, and Blood Institute (NHLBI).

Dr. Maciejewski served as Staff Scientist at NHLBI before joining Cleveland Clinic in 2001 as Staff Physician and Section Head of Experimental Hematology. In January 2009, he was appointed Chairman of the newly created Department of Translational Hematology and Oncology Research at Taussig Cancer Institute (THOR).




Navneet Majhail, MD

Cleveland Clinic Main Campus

Navneet Majhail, MD, is Director of the Blood and Marrow Transplant program at Taussig Cancer Institute.

Dr. Majhail attended medical school at Government Medical College in India. He completed a residency at Cleveland Clinic and a fellowship at University of Minnesota in Minneapolis, MN.




Keith McCrae, MD

Cleveland Clinic Main Campus

Keith McCrae, MD, earned his undergraduate degree at Dartmouth College and continued on to earn his medical degree from Duke University School of Medicine.

Dr. McCrae completed his residency at Duke University Children's Hospital & Medical Center. Later, he completed a fellowship at The University of Pennsylvania.




Susan McInnes, MD

Cleveland Clinic Main Campus

Susan McInnes, MD, is a Staff physician in the Department of Hematology & Medical Oncology at Cleveland Clinic.

Dr. McInnes completed medical school at the Medical College of Ohio at Toledo. She then completed both a residency and fellowship at University of Chicago Medical Center and an additional fellowship at Michael Reese Hospital & Medical Center in Chicago, IL.




Michael McNamara, MD

Cleveland Clinic Main Campus

Michael McNamara, MD, was appointed Associate Staff at Cleveland Clinic Taussig Cancer Institute in 2008. He completed his undergraduate degree at The Ohio State University and attended medical school at Case Western Reserve University. He then completed his internship, residency, and fellowship at University of Pittsburgh Medical Center.

Some of his special interests include esophageal cancer, pancreatic cancer, stomach cancer, and solid tumor disorders.




Alberto Montero, MD

Cleveland Clinic Main Campus

Alberto J. Montero, MD, is a Staff member in the Department of Hematology & Medical Oncology and Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine.

Dr. Montero attended medical school at University of Texas Medical School at Galveston. He completed a residency at University of Texas Health Science Center at Houston and a fellowship at University of Texas MD Anderson Cancer Center in Houston, TX.




Halle Moore, MD

Cleveland Clinic Main Campus

Halle Moore, MD, is a Staff Physician in the Department of Hematology & Medical Oncology at Cleveland Clinic's Taussig Cancer Institute. She is also a clinical member of the Case Comprehensive Cancer Center, Cancer Prevention, Control and Population Research Program.

Dr. Moore is board-certified in internal medicine, medical oncology and hematology. Her clinical practice focuses on the medical management of breast cancer. Her research involves the investigation of new treatments for breast cancer as well as the study of long-term effects of cancer treatment, including effects on fertility, bone health and cognitive function. In addition, Dr. Moore serves on the Board of Trustees for the Northern Ohio Breast Cancer Coalition.




Sudipto Mukherjee, MD

Cleveland Clinic Main Campus

Sudipto Mukherjee, MD, MPH, is an Associate Staff Physician in the Department of Hematology & Medical Oncology.

Dr. Mukherjee earned his medical degree from the Nil Ratan Sircar Medical College in India. He completed residency training at the William Beaumont School of Medicine at Oakland University in Royal Oak, MI, and a fellowship at Cleveland Clinic.




Kathleen Neuendorf, MD

Cleveland Clinic Main Campus

Kathleen Neuendorf, MD, earned her undergraduate degree at College of Wooster and her medical degree at Medical College of Ohio in Toledo. She completed a residency at Grant/Riverside Methodist Hospitals and a fellowship in Palliative Medicine at Medical College of Wisconsin Clinics

Some of her specialty interests include Palliative care in non-cancer diagnoses.




Tobenna Nwizu, MD

Cleveland Clinic Main Campus

Tobenna Nwizu, MD, is an Associate Staff Physician in the Department of Hematology & Medical Oncology at Taussig Cancer Institute.

Dr. Nwizu attended medical school at the University of Ibadan Faculty of Medicine in Nigeria. He completed a residency at John H. Stroger Jr. Hospital of Cook County in Chicago and a fellowship at University of Chicago Hospitals.




Armida Parala-Metz, MD

Cleveland Clinic Main Campus

Armida Parala-Metz, MD, earned her medical degree at University of the East in Manila, Phillipines. She completed a residency and a fellowship in geriatrics at Maimonides Medical Center and another fellowship at Cleveland Clinic in Hospice and Palliative Medicine.

Some of her specialty interests include cancer pain, geriatrics, pain and symptom management, and palliative medicine.




Chirag Patel, MD

Cleveland Clinic Main Campus

Chirag Patel, MD, is an Associate Staff Physician in the Department of Hematology & Medical Oncology at Taussig Cancer Institute.

Dr. Patel attended medical school at Northeastern Ohio Universities College of Medicine in Rootstown, OH. He completed residency training at Pitt County Memorial Hospital in Greenville, NC, and a fellowship at University of Texas MD Anderson Cancer Center in Houston, TX. His specialty interest is palliative medicine.




David Peereboom, MD

Cleveland Clinic Main Campus

David Peereboom, MD, is a joint staff member at Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center and Cleveland Clinic Taussig Cancer Institute. He is a medical oncologist specializing in the management of brain tumors.

A graduate of the Virginia Commonwealth University Medical College in Richmond, Va., Dr. Peereboom received his specialty training at University Hospitals of Cleveland and the Johns Hopkins Oncology Center in Baltimore. His specialty interests include neuro-oncology and experimental therapeutics.




Robert Pelley, MD

Cleveland Clinic Main Campus

Robert J. Pelley, MD, is a Staff member in the Department of Hematology & Medical Oncology at Taussig Cancer Institute. Dr. Pelley is board-certified in internal medicine with subspecialties in hematology and medical oncology. His clinical interests include gastrointestinal tumors.

Dr. Pelley received his medical degree from the University of Cincinnati in Ohio. He completed his internship, residency and fellowship in hematology and oncology at University Hospitals of Cleveland. Dr. Pelley served as Program Director of the Hematology/Medical Oncology Fellowship for nearly 10 years and continues to take an active role in the education of young hematologists and oncologists in training.




Nathan Pennell, MD, PhD

Cleveland Clinic Main Campus

Dr. Pennell is a board certified medical oncologist who joined the staff at Taussig Cancer Institute in 2008. He specializes in the treatment of thoracic malignancies with a focus on lung cancer. Dr. Pennell's research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic.

In 1998, Dr. Pennell received his PhD in neuroscience and his medical degree in 2002 from the University of Florida College of Medicine in Gainesville, FL. Dr. Pennell completed his internal medicine residency in 2005 at Brigham and Women's Hospital in Boston, MA. His medical oncology fellowship training was completed in 2007 at the Dana Farber Cancer Institute.




Brad Pohlman, MD

Cleveland Clinic Main Campus

Brad Pohlman, MD, is Vice Chair of Operations, Director of the Lymphoma Program, and Director of The Scott Hamilton CARES Initiative at Cleveland Clinic Taussig Cancer Institute.

Dr. Pohlman is a member of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Blood and Marrow Transplantation.

Dr. Pohlman's specialty interests include Castleman's disease, hemophilia, HIV-related lymphoma, Hodgkin's disease, non-Hodgkin's lymphoma, and post-transplant lymphoproliferative disorder.




Frederic Reu, MD

Cleveland Clinic Main Campus

Frederic Reu, MD, earned his medical degree at Eberhard-Karls Universitat Tubingen in Tubingen, Germany. At Cleveland Clinic, he completed an internship in internal medicine, a residency in medical oncology, and a fellowship in medical oncology.

Dr. Reu's specialty interests include multiple myeloma, light chain amyloidosis, and plasma cell disorders.




Brian Rini, MD

Cleveland Clinic Main Campus

Brian I. Rini, MD, is an Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. A Staff member of the Department of Hematology & Medical Oncology, Dr. Rini’s work focuses on genitourinary malignancies.

Dr. Rini earned his medical degree at The Ohio State University College of Medicine in Columbus, Ohio. After completing a residency program in internal medicine at University of Chicago Hospitals in Illinois, Dr. Rini was awarded a fellowship in hematology and oncology at the University of Chicago. Dr. Rini was an Assistant Professor at the University of California San Francisco before moving to Cleveland Clinic.




Christy Samaras, DO

Cleveland Clinic Main Campus

Christy Samaras, DO, earned her undergraduate degree at Eastern Nazarene College in Wollaston, MA, and then received her medical degree from The University of New England College of Osteopathic Medicine.

Dr. Samaras continued on to complete a residency at Mercy Hospital of Pittsburgh and a fellowship at Cleveland Clinic, where she was appointed Associate Staff in the Department of Hematology & Medical Oncology.




Yogen Saunthararajah, MD

Cleveland Clinic Main Campus

Yogen Saunthararajah, MD, is Associate Staff in the Department of Hematology & Medical Oncology at Cleveland Clinic, and an Associate Professor.

Dr. Saunthararajah received his undergraduate and medical degrees from the University of Wales College of Medicine, and completed medical and surgical internships at University Hospitals of Wales, United Kingdom. Dr. Sauntharajah served as a Captain in Military Medicine in the Singapore Armed Forces.




Mikkael Sekeres, MD, MS

Cleveland Clinic Main Campus

Mikkael Sekeres, MD, MS, earned his undergraduate and medical degrees at the University of Pennsylvania. He then completed a residency in internal medical at Massachusetts General Hospital and stayed in Boston to complete a fellowship in hematology and oncology at Dana-Farber Cancer Institute.

Some of Dr. Sekeres' specialty interests include: acute myeloid leukemia, bone marrow failure syndromes/disorders, chronic myelogenous leukemia, myelodysplastic syndromes, myeloproliferative neoplasms, hairy cell leukemia, chronic lymphocytic leukemia, and acute lymphocytic leukemia.




Marc Shapiro, MD

Cleveland Clinic Main Campus

Marc Shapiro, MD, was born and raised in Cleveland, Ohio. He attended medical school at the Medical College of Ohio in Toledo. He completed his internal medicine training at Emory University in Atlanta, Ga., and earned his board certification in internal medicine in 2001. Dr. Shapiro completed his specialty training in medical oncology and hematology at Fox Chase Cancer Center and Temple University in Philadelphia, Pa. He is now a Staff member in the Department of Hematology & Medical Oncology at Cleveland Clinic.

Dr. Shapiro's clinical interests include the treatment of lung, breast, gastrointestinal and colon cancers.




Dale Shepard, MD, PhD

Cleveland Clinic Main Campus

Dale Shepard, MD, PhD, received his doctorate at The Ohio State University, and later received his medical degree at The Ohio State University College of Medicine and Public Health. He completed a Research Fellowship of Clinical Pharmacology at the University of Chicago, and then later completed a residency and fellowship at Cleveland Clinic.

Some of his specialty interests include genitourinary oncology, geriatric oncology, and experimental therapeutics.




Laura Shoemaker, DO

Cleveland Clinic Main Campus

Laura Shoemaker, DO is an Associate Staff physician in the Department of Hematology & Oncology at Cleveland Clinic.

Dr. Shoemaker completed medical school at Ohio University College of Osteopathic Medicine in Athens, OH. She completed an internship at Northside Hospital & Heart Institute in St. Petersburg, FL. Dr. Shoemaker then completed both a residency and fellowship at Cleveland Clinic.




Bernard Silver, MD

Cleveland Clinic Main Campus

Bernard Silver, MD, earned his medical degree from the University of Michigan Medical School in Ann Arbor, Mich. He completed an internship and residency at Northwestern University Evanston Hospital. He then completed a fellowship at University of Michigan Health System in Ann Arbor.

His specialty interests include coagulation disorders, hemophilia, Von Willebrand's disease, clotting factor deficiencies or inhibitors, thrombophilia, Lupus anticoagulant/antiphospholipid syndrome, thrombocytopenia (ITP, TTP), and hemolytic anemia.




Mitchell Smith, MD

Cleveland Clinic Main Campus

Mitchell Smith, MD, joined Cleveland Clinic Taussig Cancer Institute in 2012 as a Section Chair for the Lymphoma and Myeloma Programs in the Department of Hematology & Medical Oncology. Dr. Smith received his MD and PhD from Case Western Reserve University in Cleveland. He completed an internship at Long Island Jewish Hospital and residencies at Barnes Hospital of Washington University School of Medicine and Jewish Hospital of St. Louis. Dr. Smith completed two fellowships at Memorial Sloan-Kettering Cancer Center in New York, NY.

Some of Dr. Smith’s specialty interests include myeloma and lymphoma.




Ronald Sobecks, MD

Cleveland Clinic Main Campus

Ronald M. Sobecks, MD, is a Staff Physician in the Department of Hematology & Medical Oncology, with joint appointment in the Transplantation Center in the Division of Surgery. Dr. Sobecks is an Assistant Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

In addition, Dr. Sobecks serves as Quality Review Officer of the Bone Marrow Transplant Program, Member and Co-Chairman of the Bone Marrow Transplant Lab Committee and Member of the Transplant Executive Committee.

Dr. Sobecks' interests include allogeneic and autologous hematopoietic stem cell transplantation, leukemia, and hematologic malignancies.




Davendra Sohal, MD

Cleveland Clinic Main Campus

Davendra Sohal, MD, is an Associate Staff Physician in the Department of Hematology & Medical Oncology at Taussig Cancer Institute. Dr. Sohal earned his medical degree from the All India Institute of Medical Sciences in New Delhi, India. He completed residency training and a year as Chief Resident in Internal Medicine at the Jacobi Medical Center of the Albert Einstein College of Medicine in Bronx, NY. Dr. Sohal completed a fellowship in Hematology/Oncology at the University of Pennsylvania in Philadelphia, PA.

Clinically, his primary interests include gastrointestinal malignancies and clinical trials.




James Stevenson, MD

Cleveland Clinic Main Campus

James Stevenson, MD, completed his undergraduate education at the University of Notre Dame. After studying medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, PA, Dr. Stevenson completed an internship at University of Florida College of Medicine at Shands Medical Center in Gainesville, FL. He completed both a residency and fellowship at Thomas Jefferson University Hospital in Philadelphia, PA.

Dr. Stevenson’s specialty interests include thoracic neoplasms and mesothelioma.




Ramon Tiu, MD

Cleveland Clinic Main Campus

Ramon Tiu, MD, is an Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine. He is an Associate Staff in the Departments of Translational Hematology and Oncology Research and Hematology & Medical Oncology.

Dr. Tiu received his medical degree from University of Santo Tomas Faculty of Medicine and Surgery in the Philippines. He pursued research training at Cleveland Clinic in experimental hematology and was appointed Associate Staff at Cleveland Clinic in 2010.




Jason Valent, MD

Cleveland Clinic Main Campus

Jason Valent, MD, is a Staff physician in the Department of Hematology & Medical Oncology at Cleveland Clinic.

Dr. Valent completed medical school at University of Cincinnati College of Medicine in Cincinnati, OH. He then completed a residency in internal medicine at University of Cincinnati Medical Center/University and a fellowship at Karmanos Cancer Institute in Detroit, MI.




Vamsidhar Velcheti, MD

Cleveland Clinic Main Campus

Vamsidhar Velcheti, MD, is an Associate Staff in the Department of Hematology & Medical Oncology at Cleveland Clinic Taussig Cancer Institute. His specialty areas include lung cancer, mesothelioma, and thymic tumors and the use of novel immunotherapies for the treatment of lung cancer. Dr. Velcheti’s clinical and translational research focuses on identifying patients with molecular changes in the tumor that can predict response to immunotherapy and expanding clinical trials focusing on immunotherapy and novel agents. Dr. Velcheti received his hematology/oncology fellowship training at the Yale-Comprehensive Cancer Center in New Haven, Connecticut. Dr. Velcheti was appointed an Associate Staff Physician in Hematology & Medical Oncology in 2013.

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

Referrals

Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2014 Cleveland Clinic. All rights reserved.

Cleveland Clinic Mobile Site